what are glp-1 agonists America's Poison Centers Frontiers | GLP-1 Receptor Agonists:

Extraglycaemic Effects on Lipids Monami et al

Active GLP-1 concentrations in portal vein significantly increased at 0.5 h and plateaued at 1 and 2 h after oral administration of d-allulose (1 g kg 1 ), returning to baseline at 3 h (Fig

10.1074/jbc.274.48.33851 13 ButeauJ.RoduitR.SusiniS.PrentkiM

Exposure to glucagon-like peptide 1 receptor agonists does not increase the risk of AKI associated with anticancer therapy: FR-OR80

Declaration of Helsinki: ethical principles for medical research involving human subjects

A small trial including 8 patients with T1D showed improved postprandial hyperglycemia despite 20% insulin dose reduction (69)